| Director Share Purchase | |
| | |
|
EMED Mining has been notified that on 2 July 2015, Jose Nicolas Sierra Lopez, a non-executive director of the Company, purchased 800,000 ordinary shares in EMED Mining at 4.75 pence per share.
Following this purchase, Dr. Sierra holds the following interests in EMED Mining
|
Number of Ordinary Shares Beneficially Owned
|
% of Company's Issued Share Capital
|
Share Options (1)
|
Jose Nicolas Sierra Lopez
|
800,000
|
0.02%
|
1,000,000
|
(1) Options were granted on 1 October 2011 and are exercisable at 9 pence per share. The options have an expiry date of 30 September 2016.
Enquiries
EMED
|
Roger Davey/Alberto Lavandeira
|
+34 959 59 28 50
|
Canaccord Genuity Limited
|
Henry Fitzgerald-O'Connor/Oliver Donaldson
|
+44 207 523 8000
|
Brandon Hill Capital
|
Oliver Stansfield
|
+44 203 463 5061
|
Walbrook PR
|
Nick Rome
|
+44 207 933 8783
|
For further information on the Company's activities, visit www.emed-mining.com.
|
|
|
EMED Mining Public Ltd
|
|
DEVELOPMENT STAGE |
CODE : EMED.L |
ISIN : CY0000100319 |
|
| |
ProfileMarket IndicatorsVALUE : Projects & res.Press releasesAnnual reportRISK : Asset profileContact Cpy |
EMED is a gold and copper development stage company based in Cyprus. EMED develops gold, copper and zinc in Cyprus and in Spain, and holds various exploration projects in Cyprus. Its main assets in development are PROYECTO RIO TINTO in Spain and KLIROU in Cyprus and its main exploration properties are DETVA, STIAVNICA-HODRUSA and BIELY VRCH in Slovakia and KLIROU in Cyprus. EMED is listed in United Kingdom. Its market capitalisation is GBX 54.7 billions as of today (US$ 65.5 billions, € 57.4 billions). Its stock quote reached its lowest recent point on September 18, 2015 at GBX 0.12, and its highest recent level on January 17, 2022 at GBX 404.00. EMED has 135 475 650 shares outstanding. |